Cold Pain Therapy Market is a therapeutic application of cold that is used to treat acute soft tissue injuries and to relieve pain in post-operative orthopedic operations, as well as the treatment of benign and malignant lesions and pain management. Topically (on the skin's surface), surgically, or percutaneously, cryotherapy can be used. Oral mucositis, tumors in the liver, kidney, bones, breasts, and lungs, skin tumors, skin tags, pre-cancerous skin moles, and traumas are among illnesses that can be treated with this.
Cryosurgery is a method that includes destroying aberrant tissues with an intense Cold Pain Therapy Market created by liquid nitrogen (or argon gas). Cryosurgery is used to treat a variety of cancers as well as some non-cancerous disorders, according to the National Cancer Institute (NCI). Early-stage skin cancer, retinoblastoma, actinic keratosis, and cervical intraepithelial neoplasia have all been documented to respond well to it. Cryotherapy was found to be helpful in managing the side effects of chemotherapy-induced peripheral neuropathy, according to a study published in the Journal of the National Cancer Institute in October 2017.
Cryotherapy is defined as the super chilling' of Cold Pain Therapy Market tissues for therapeutic purposes, according to the United States Food and Drug Administration (FDA). Furthermore, cryotherapy entails the use of ice packs to a specific area of the body, such as the lower back. WBC includes exposing the body to liquid nitrogen vapors to achieve an ultra-low temperature of -200 to -300 degrees Fahrenheit. For two to four minutes, WBCs are treated in relatively tight areas or chambers. The FDA in the United States, on the other hand, does not have enough data to advocate the use of WBC to treat diseases or disorders including Alzheimer's disease, rheumatoid arthritis, stress, multiple sclerosis, anxiety, or chronic pain. Burns, frostbite, and eye injury are all possible side effects of using WBC.
Market advances in the field of cold pain therapy
CSA Medical, Inc. gained FDA approval in July 2017 to expand its truFreeze catheter offering to include the Rapid AV Spray Kit. The truFreeze system is used in cryosurgical treatments for gynecology, dermatology, general surgery, and the removal of malignant lesions in gynecology, dermatology, and general surgery. In addition, the use of a fast AV Spray kit with a truFreeze catheter is projected to shorten the surgical time and thereby shorten overall patient treatment time.
The following are the major participants in the cold pain therapy market:
CryoConcepts LP, Metrum Cryoflex, Brymill Cryogenic Systems, Medtronic Mediccale S.r.l., Sanarus, Wallach Surgical Devices, Zimmer MedizinSystems, CooperSurgical Inc., CSA Medical, Inc., Cortex Technology, Erbe Elektromedizin, GmbH, Special Medical Technology Co., Ltd, Medtronic plc, Galil Medical, Inc., and PHYSIOMED AG are some of the leading companies in
0 Comments